Bredella Miriam A, Greenblatt Logan B, Eajazi Alireza, Torriani Martin, Yu Elaine W
Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Bone. 2017 Feb;95:85-90. doi: 10.1016/j.bone.2016.11.014. Epub 2016 Nov 15.
Bariatric surgery is associated with bone loss but skeletal consequences may differ between Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), the two most commonly performed bariatric procedures. Furthermore, severe weight loss is associated with high marrow adipose tissue (MAT); however, MAT is also increased in visceral adiposity. The purpose of our study was to determine the effects of RYGB and SG on BMD and MAT. We hypothesized that both bariatric procedures would lead to a decrease in BMD and MAT. We studied 21 adults with morbid obesity (mean BMI 44.1±5.1kg/m) prior to and 12months after RYGB (n=11) and SG (n=10). All subjects underwent DXA and QCT of the lumbar spine and hip to assess aBMD and vBMD. Visceral (VAT) and subcutaneous (SAT) adipose tissue was quantified at L1-L2. MAT of the lumbar spine and femur was assessed by 1H-MR spectroscopy. Calcitropic hormones and bone turnover markers were determined. At 12months after surgery, mean weight and abdominal fat loss was similar between the RYGB and SG groups. Mean serum calcium, 25(OH)-vitamin D, and PTH levels were unchanged after surgery and within the normal range in both groups. Bone turnover markers P1NP and CTX increased within both groups and P1NP increased to a greater extent in the RYGB group (p=0.03). There were significant declines from baseline in spine aBMD and vBMD within the RYGB and SG groups, although the changes were not significantly different between groups (p=0.3). Total hip and femoral neck aBMD by DXA decreased to a greater extent in the RYGB than the SG group (p<0.04) although the change in femoral vBMD by QCT was not significantly different between groups (p>0.2). MAT content of the lumbar spine and femoral diaphysis did not change from baseline in the RYGB group but increased after SG (p=0.03). Within the SG group, 12-month change in weight and VAT were positively associated with 12-month change in MAT (p<0.04), suggesting that subjects with less weight and VAT loss had higher MAT. In conclusion, RYGB and SG are associated with declines in lumbar spine BMD, however, the changes are not significantly different between the groups. RYGB may be associated with greater decline of aBMD at the total hip and femoral neck compared to SG. MAT content increased after SG and this was associated with lower weight and VAT loss.
减重手术与骨质流失相关,但在两种最常见的减重手术——Roux-en-Y胃旁路术(RYGB)和袖状胃切除术(SG)中,骨骼方面的后果可能有所不同。此外,严重体重减轻与高骨髓脂肪组织(MAT)有关;然而,内脏肥胖中MAT也会增加。我们研究的目的是确定RYGB和SG对骨密度(BMD)和MAT的影响。我们假设这两种减重手术都会导致BMD和MAT下降。我们研究了21名患有病态肥胖的成年人(平均BMI为44.1±5.1kg/m²),在RYGB(n = 11)和SG(n = 10)手术前及术后12个月进行观察。所有受试者均接受腰椎和髋部的双能X线吸收法(DXA)和定量CT(QCT)检查,以评估骨密度(aBMD)和体积骨密度(vBMD)。在L1-L2水平对内脏(VAT)和皮下(SAT)脂肪组织进行定量分析。通过氢质子磁共振波谱(1H-MR光谱)评估腰椎和股骨的MAT。测定骨代谢相关激素和骨转换标志物。术后12个月,RYGB组和SG组的平均体重和腹部脂肪减少情况相似。两组术后血清钙、25(OH)-维生素D和甲状旁腺激素(PTH)水平均未改变,且在正常范围内。两组的骨转换标志物I型前胶原氨基端前肽(P1NP)和I型胶原交联C末端肽(CTX)均升高,且RYGB组P1NP升高幅度更大(p = 0.03)。RYGB组和SG组的脊柱aBMD和vBMD较基线均有显著下降,尽管两组间变化无显著差异(p = 0.3)。DXA测量的全髋和股骨颈aBMD在RYGB组比SG组下降幅度更大(p < 0.04),尽管QCT测量的股骨vBMD组间变化无显著差异(p > 0.2)。RYGB组腰椎和股骨干的MAT含量与基线相比无变化,但SG组术后增加(p = 0.03)。在SG组中,术后12个月体重和VAT的变化与MAT的变化呈正相关(p < 0.04),表明体重和VAT减少较少的受试者MAT较高。总之,RYGB和SG均与腰椎BMD下降有关,但两组间变化无显著差异。与SG相比,RYGB可能与全髋和股骨颈aBMD下降幅度更大有关。SG术后MAT含量增加,且这与较低的体重和VAT减少有关。